Chief Executive Officer at EMGenisys.
Earliest Form D on file: Mar 2026
Smartphone video scoring of livestock embryo viability
Biotech, Houston TX
Signed as Chief Executive Officer
$521K
sold of $1.5M offered
Form D
LinkedIn
Reported on an amendment to an earlier filing.
Michael Rea
Director
Mike Jung
Thomas Smith
Browse by sector
Browse by state